Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature Medicine 13, 1086 - 1095 (2007)
Published online: 26 August 2007 | doi:10.1038/nm1626
Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype
Eugene A Podrez1, Tatiana V Byzova1,2,8, Maria Febbraio3,8, Robert G Salomon4, Yi Ma1, Manojkumar Valiyaveettil1, Eugenia Poliakov4, Mingjiang Sun3,5, Paula J Finton3, Brian R Curtis6, Juhua Chen1,2, Renliang Zhang3,5, Roy L Silverstein3 & Stanley L Hazen3,5,7
Abstract
Dyslipidemia is associated with a prothrombotic phenotype; however, the mechanisms responsible for enhanced platelet reactivity remain unclear. Proatherosclerotic lipid abnormalities are associated with both enhanced oxidant stress and the generation of biologically active oxidized lipids, including potential ligands for the scavenger receptor CD36, a major platelet glycoprotein. Using multiple mouse in vivo thrombosis models, we now demonstrate that genetic deletion of Cd36 protects mice from hyperlipidemia-associated enhanced platelet reactivity and the accompanying prothrombotic phenotype. Structurally defined oxidized choline glycerophospholipids that serve as high-affinity ligands for CD36 were at markedly increased levels in the plasma of hyperlipidemic mice and in the plasma of humans with low HDL levels, were able to bind platelets via CD36 and, at pathophysiological levels, promoted platelet activation via CD36. Thus, interactions of platelet CD36 with specific endogenous oxidized lipids play a crucial role in the well-known clinical associations between dyslipidemia, oxidant stress and a prothrombotic phenotype.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
The clot thickens?oxidized lipids and thrombosisNature Medicine News and Views (01 Sep 2007)
Getting to the core of atherosclerosisNature Medicine News and Views (01 Oct 2008)
RESEARCH
Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiencyNature Medicine Article (01 Jul 2001)
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDLNature Medicine Article (01 Jun 2003)
